Evidence map›Paper›PMID 30745962›Full record

ArticleOpen access Macedonian journal of medical sciences2019

Early Treatment with Imiquimod 5% Cream of Periungual Warts in Vietnam: The Poorer, the Better.

Phuong Pham Thi Minh, Loan Pham Thi, Anh Tran Lan, Thuong Nguyen Van, Hung Le Van, Van Tran Cam, Marco Gandolfi, Claudio Feliciani, Francesca Satolli, Michael Tirant and 2 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open access Macedonian journal of medical sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Phuong Pham Thi MinhNational Hospital of Dermatology and Venereology, Hanoi, Vietnam.
Loan Pham ThiNational Hospital of Dermatology and Venereology, Hanoi, Vietnam.
Anh Tran LanNational Hospital of Dermatology and Venereology, Hanoi, Vietnam.
Thuong Nguyen VanNational Hospital of Dermatology and Venereology, Hanoi, Vietnam.
Hung Le VanNational Hospital of Dermatology and Venereology, Hanoi, Vietnam.
Van Tran CamNational Hospital of Dermatology and Venereology, Hanoi, Vietnam.
Marco GandolfiUnit of Dermatology, University of Parma, Parma, Italy.
Claudio FelicianiUnit of Dermatology, University of Parma, Parma, Italy.
Francesca SatolliUnit of Dermatology, University of Parma, Parma, Italy.
Michael TirantUniversity of Rome G. Marconi, Rome, Italy.
Aleksandra VojvodicDepartment of Dermatology and Venereology, Military Medical Academy of Belgrade, Belgrade, Serbia.
Torello LottiUniversity of Rome G. Marconi, Rome, Italy.
Hanoi Medical University · VNNational Hospital of Pediatrics · VNUniversity of Parma · ITMarconi University · ITMilitary Medical Academy · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo evaluate the efficacy of imiquimod 5% in periungual wart treatment. MATERIAL AND

methodsA group of 40 patients were recruited to apply imiquimod 5 % cream once daily for 5 consecutive days per week in 8 weeks. They were classified into 3 levels: Mild (the total lesion area ≤ 25 mm

resultsThe total area of the wart lesion got decreased significantly from the beginning to the 4

conclusionIn conclusion, Imiquimod 5% cream is a safe and effective drug in the treatment of periungual warts.

Indexed as

ImiquimodPeriungual warts

Identifiers

PMID30745962
PMCPMC6364714
OpenAlexW2913798383

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.